November 3–5, 2025
Vienna Congress and Convention Center, Vienna, AustriaNovember 11–12, 2025 | Digital Partnering David GaudenCEO at Blue Earth TherapeuticsSpeaker
Profile
David was a co-founder of our sister company Blue Earth Diagnostics. As Chief Scientific Officer, and later Chief Executive Officer, he was instrumental in building the company from a start-up in 2014 to a successful leader in nuclear medicine and molecular imaging prior to its acquisition by Bracco Imaging in 2019. David also led the spin-out of Blue Earth Therapeutics from Bracco in 2021. Prior to founding Blue Earth Diagnostics, David was Product Leader for Oncology Molecular Imaging at GE Healthcare. With more than 25 years in the radiopharmaceuticals industry, David has deep experience across the field. He has a degree in biotechnology from Warwick University and a doctorate in biochemistry from Oxford University.